The Mount Sinai Health System (New York, NY), Emergent BioSolutions (Gaithersburg, MD) and ImmunoTek Bio Centers (New Orleans, LA) will collaborate to develop, manufacture and conduct clinical trials to evaluate Emergent’s COVID-19 hyperimmune globulin product, COVID-HIG, including a post-exposure prophylaxis (PEP) study on healthcare providers at high risk of COVID-19 … [Read more...]